Emanuele Di Angelantonio

Emanuele Di Angelantonio's AcademicInfluence.com Rankings

Philosophy

#9175

World Rank

#12695

Historical Rank

Logic

#6165

World Rank

#7653

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Emanuele Di Angelantonio's Degrees

Bachelors Biomedical Sciences University of Milan

Why Is Emanuele Di Angelantonio Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Emanuele Di Angelantonio's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. (2010) (1978)
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis (2010) (1950)
Diabetes mellitus, fasting glucose, and risk of cause-specific death. (2011) (1874)
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents (2016) (1582)
Major lipids, apolipoproteins, and risk of vascular disease. (2009) (1563)
Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. (2009) (1329)
Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. (2014) (1046)
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. (2021) (961)
C-reactive protein, fibrinogen, and cardiovascular disease prediction. (2012) (952)
The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease (2016) (885)
Prevalence of Depression and Depressive Symptoms Among Resident Physicians: A Systematic Review and Meta-analysis. (2015) (793)
Association of apolipoprotein E genotypes with lipid levels and coronary risk. (2007) (731)
Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies (2018) (727)
Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies (2018) (727)
Genetic associations with valvular calcification and aortic stenosis. (2013) (723)
Hypertension in India: a systematic review and meta-analysis of prevalence, awareness, and control of hypertension (2014) (690)
Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies (2012) (646)
Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies (2010) (631)
Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. (2011) (589)
Lipoprotein-associated phospholipase A2 and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies (2010) (588)
Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. (2014) (568)
Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data (2011) (556)
Association of Cardiometabolic Multimorbidity With Mortality. (2015) (535)
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. (2016) (529)
Rare and low-frequency coding variants alter human adult height (2016) (511)
Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk. (2008) (493)
Association analyses based on false discovery rate implicate new loci for coronary artery disease (2017) (476)
Lipid-related markers and cardiovascular disease prediction. (2012) (457)
The Age-Specific Quantitative Effects of Metabolic Risk Factors on Cardiovascular Diseases and Diabetes: A Pooled Analysis (2013) (456)
Mapping the human genetic architecture of COVID-19 (2021) (455)
Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis. (2014) (454)
Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease (2016) (434)
Exome-wide association study of plasma lipids in >300,000 individuals (2017) (428)
An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke (2013) (425)
World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions (2019) (423)
Genetics of Blood Lipids Among ~300,000 Multi-Ethnic Participants of the Million Veteran Program (2018) (387)
Impact of Healthy Lifestyle Factors on Life Expectancies in the US Population (2018) (380)
B-Type Natriuretic Peptides and Cardiovascular Risk: Systematic Review and Meta-Analysis of 40 Prospective Studies (2009) (361)
Genomic Risk Prediction of Coronary Artery Disease in 480,000 Adults (2018) (359)
Association of Triglyceride-Lowering LPL Variants and LDL-C–Lowering LDLR Variants With Risk of Coronary Heart Disease (2019) (356)
Association of LPA Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies: A Mendelian Randomization Analysis (2018) (340)
Lipoprotein(a) levels and risk of future coronary heart disease: large-scale prospective data. (2008) (259)
Chronic kidney disease and risk of major cardiovascular disease and non-vascular mortality: prospective population based cohort study (2010) (258)
A catalog of genetic loci associated with kidney function from analyses of a million individuals (2019) (252)
Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression (2006) (250)
BMPR2 mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis (2016) (249)
Environmental toxic metal contaminants and risk of cardiovascular disease: systematic review and meta-analysis (2018) (243)
The Polygenic and Monogenic Basis of Blood Traits and Diseases (2020) (242)
Apolipoprotein(a) isoforms and the risk of vascular disease: systematic review of 40 studies involving 58,000 participants. (2010) (241)
Trans-ancestry meta-analyses identify rare and common variants associated with blood pressure and hypertension (2016) (234)
Chocolate consumption and cardiometabolic disorders: systematic review and meta-analysis (2011) (231)
Cardiovascular disease risk prediction using automated machine learning: A prospective study of 423,604 UK Biobank participants (2019) (228)
Trans-ethnic and Ancestry-Specific Blood-Cell Genetics in 746,667 Individuals from 5 Global Populations (2020) (225)
Fifteen new risk loci for coronary artery disease highlight arterial-wall-specific mechanisms (2017) (224)
Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: individual participant meta-analysis. (2012) (220)
Separate and combined associations of obesity and metabolic health with coronary heart disease: a pan-European case-cohort analysis (2018) (202)
SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. (2021) (200)
Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure underpinning obesity (2017) (193)
Efficiency and safety of varying the frequency of whole blood donation (INTERVAL): a randomised trial of 45 000 donors (2017) (190)
Efficiency and safety of varying the frequency of whole blood donation (INTERVAL): a randomised trial of 45 000 donors (2017) (190)
Glycated hemoglobin measurement and prediction of cardiovascular disease. (2014) (189)
High-Sensitivity Cardiac Troponin Concentration and Risk of First-Ever Cardiovascular Outcomes in 154,052 Participants (2017) (180)
Identification of new susceptibility loci for type 2 diabetes and shared etiological pathways with coronary heart disease (2017) (179)
Mendelian Randomization Study of ACLY and Cardiovascular Disease (2019) (166)
Identification of novel risk loci for restless legs syndrome in genome-wide association studies in individuals of European ancestry: a meta-analysis (2017) (156)
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases (2007) (155)
Prognostic significance of admission levels of troponin I in patients with acute ischaemic stroke (2004) (153)
Cardiovascular Risk Factors Associated With Venous Thromboembolism (2019) (143)
Asymmetric Dimethylarginine and Cardiovascular Risk: Systematic Review and Meta-Analysis of 22 Prospective Studies (2015) (130)
Atrial Natriuretic Peptide Gene Polymorphisms and Risk of Ischemic Stroke in Humans (2004) (115)
Hemostatic Factors and Risk of Coronary Heart Disease in General Populations: New Prospective Study and Updated Meta-Analyses (2013) (114)
Body mass index and all cause mortality in HUNT and UK Biobank studies: linear and non-linear mendelian randomisation analyses (2019) (113)
Whole-Genome Sequencing Coupled to Imputation Discovers Genetic Signals for Anthropometric Traits (2017) (110)
Cardiometabolic effects of genetic upregulation of the interleukin 1 receptor antagonist: a Mendelian randomisation analysis (2015) (106)
The INTERVAL trial to determine whether intervals between blood donations can be safely and acceptably decreased to optimise blood supply: study protocol for a randomised controlled trial (2014) (106)
Anticoagulant vs. antiplatelet therapy in patients with cryptogenic stroke and patent foramen ovale: an individual participant data meta-analysis. (2015) (100)
Renal Function and Risk of Coronary Heart Disease in General Populations: New Prospective Study and Systematic Review (2007) (99)
Recurrent stroke predictors differ in medically treated patients with pathogenic vs other PFOs (2014) (98)
Increased plasma levels of oxysterols, in vivo markers of oxidative stress, in patients with familial combined hyperlipidemia: reduction during atorvastatin and fenofibrate therapy. (2007) (85)
Long-term prognostic significance of three-dimensional echocardiographic parameters of the left ventricle and left atrium. (2010) (85)
Genome-wide analysis identifies molecular systems and 149 genetic loci associated with income (2019) (85)
SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions. (2021) (83)
Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysis (2016) (83)
Association Between Depressive Symptoms and Incident Cardiovascular Diseases. (2020) (82)
Polygenic basis and biomedical consequences of telomere length variation (2021) (79)
Estimating dose-response relationships for vitamin D with coronary heart disease, stroke, and all-cause mortality: observational and Mendelian randomisation analyses (2021) (79)
N-terminal pro-brain natriuretic Peptide is a more useful predictor of cardiovascular disease risk than C-reactive protein in older men with and without pre-existing cardiovascular disease. (2011) (78)
Equalization of four cardiovascular risk algorithms after systematic recalibration: individual-participant meta-analysis of 86 prospective studies (2018) (78)
Mid- and Long-Term Health Risks in Living Kidney Donors (2018) (74)
Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19 (2020) (73)
Meta-analysis of up to 622,409 individuals identifies 40 novel smoking behaviour associated genetic loci (2019) (72)
Levels of circulating procoagulant microparticles in nonvalvular atrial fibrillation. (2007) (70)
Identification of professional scuba divers with patent foramen ovale at risk for decompression illness. (2004) (70)
Left ventricular remodelling index (LVRI) in various pathophysiological conditions: a real-time three-dimensional echocardiographic study (2005) (69)
PROTEIN-CODING VARIANTS IMPLICATE NOVEL GENES RELATED TO LIPID HOMEOSTASIS CONTRIBUTING TO BODY FAT DISTRIBUTION (2018) (67)
Consumption of Meat, Fish, Dairy Products, and Eggs and Risk of Ischemic Heart Disease (2019) (65)
Association of the 9p21.3 Locus With Risk of First-Ever Myocardial Infarction in Pakistanis: Case-Control Study in South Asia and Updated Meta-Analysis of Europeans (2010) (65)
Association of Multiple Biomarkers of Iron Metabolism and Type 2 Diabetes: The EPIC-InterAct Study (2016) (65)
Linked electronic health records for research on a nationwide cohort of more than 54 million people in England: data resource (2021) (62)
Percutaneous coronary intervention in HIV infected patients: immediate results and long term prognosis (2005) (62)
Gene polymorphisms of the renin–angiotensin–aldosterone system and the risk of ischemic stroke: a role of the A1166C/AT1 gene variant (2004) (60)
Polygenic risk scores in cardiovascular risk prediction: A cohort study and modelling analyses (2021) (60)
Oral or parenteral iron supplementation to reduce deferral, iron deficiency and/or anaemia in blood donors. (2014) (59)
Transesophageal Echocardiography in Cryptogenic Stroke and Patent Foramen Ovale: Analysis of Putative High-Risk Features From the Risk of Paradoxical Embolism Database (2014) (58)
Neuroimaging Findings in Cryptogenic Stroke Patients With and Without Patent Foramen Ovale (2013) (58)
Evaluation of Effectiveness and Cost‐Effectiveness of a Clinical Decision Support System in Managing Hypertension in Resource Constrained Primary Health Care Settings: Results From a Cluster Randomized Trial (2015) (56)
Collaborative meta-analysis of individual participant data from observational studies of Lp-PLA2 and cardiovascular diseases. (2007) (55)
Systematically missing confounders in individual participant data meta-analysis of observational cohort studies (2009) (54)
Automated typing of red blood cell and platelet antigens: a whole-genome sequencing study. (2018) (54)
Discovery of rare variants associated with blood pressure regulation through meta-analysis of 1.3 million individuals (2020) (53)
Parity, breastfeeding and risk of coronary heart disease: A pan-European case–cohort study (2016) (53)
N-terminal pro-B-type natriuretic peptide and the prediction of primary cardiovascular events: results from 15-year follow-up of WOSCOPS (2012) (52)
Assessing Risk Prediction Models Using Individual Participant Data From Multiple Studies (2013) (52)
Types of Stroke Recurrence in Patients with Ischemic Stroke: A Substudy from the PRoFESS Trial (2014) (52)
[2021 ESC Guidelines on cardiovascular disease prevention in clinical practice]. (2022) (50)
Determinants of plasma levels of brain natriuretic peptide after acute ischemic stroke or TIA (2007) (50)
Coronary artery bypass graft in HIV-infected patients: a multicenter case control study. (2008) (49)
Markers of Inflammation and Risk of Coronary Heart Disease (2009) (49)
The Risk of Paradoxical Embolism (RoPE) Study: Initial Description of the Completed Database (2013) (48)
Lipoprotein‐associated phospholipase A2 activity and mass in relation to vascular disease and nonvascular mortality (2010) (47)
Haemostatic and inflammatory markers are independently associated with myocardial infarction in men and women. (2012) (47)
Genetic Determinants of Lipids and Cardiovascular Disease Outcomes (2019) (47)
Left Ventricular Mass and the Risk of Sudden Cardiac Death: A Population‐Based Study (2014) (46)
Validation of a Genome-Wide Polygenic Score for Coronary Artery Disease in South Asians. (2020) (45)
Exome Chip Meta-analysis Fine Maps Causal Variants and Elucidates the Genetic Architecture of Rare Coding Variants in Smoking and Alcohol Use (2019) (45)
Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity (2019) (45)
Measures to assess the prognostic ability of the stratified Cox proportional hazards model (2009) (44)
Prevalence of restless legs syndrome and associated factors in an otherwise healthy population: results from the Danish Blood Donor Study. (2017) (44)
The associations of major foods and fibre with risks of ischaemic and haemorrhagic stroke: a prospective study of 418 329 participants in the EPIC cohort across nine European countries (2020) (44)
T-wave inversion, QRS duration, and QRS/T angle as electrocardiographic predictors of the risk for sudden cardiac death. (2014) (43)
High-Sensitivity Cardiac Troponin and New-Onset Heart Failure: A Systematic Review and Meta-Analysis of 67,063 Patients With 4,165 Incident Heart Failure Events. (2018) (42)
A genome-wide meta-analysis yields 46 new loci associating with biomarkers of iron homeostasis (2021) (40)
Association of menopausal characteristics and risk of coronary heart disease: a pan-European case–cohort analysis (2019) (39)
Association of anthropometry and weight change with risk of dementia and its major subtypes: A meta‐analysis consisting 2.8 million adults with 57 294 cases of dementia (2020) (38)
Accuracy of UK Rapid Test Consortium (UK-RTC) “AbC-19 Rapid Test” for detection of previous SARS-CoV-2 infection in key workers: test accuracy study (2020) (37)
Association of Dietary, Circulating, and Supplement Fatty Acids With Coronary Risk (2014) (37)
Relation of left atrial maximal volume measured by real-time 3D echocardiography to demographic, clinical, and Doppler variables. (2008) (37)
Screening for chronic comorbid diseases in people with HIV: the need for a strategic approach (2013) (37)
Use of Repeated Blood Pressure and Cholesterol Measurements to Improve Cardiovascular Disease Risk Prediction: An Individual-Participant-Data Meta-Analysis (2017) (37)
Factors influencing the level of circulating procoagulant microparticles in acute pulmonary embolism. (2010) (35)
Comparison of donor and general population demographics over time: a BEST Collaborative group study (2017) (35)
C-reactive protein and transesophageal echocardiographic markers of thromboembolism in patients with atrial fibrillation. (2012) (35)
Polymorphisms in prothrombotic genes and their impact on ischemic stroke in a Sardinian population (2005) (35)
Usefulness of Tricuspid Annular Velocity in Identifying Global RV Dysfunction in Patients with Primary Pulmonary Hypertension: A Comparison with 3D Echo‐Derived Right Ventricular Ejection Fraction (2008) (33)
Association of COVID-19 vaccines ChAdOx1 and BNT162b2 with major venous, arterial, or thrombocytopenic events: A population-based cohort study of 46 million adults in England (2022) (32)
The Bangladesh Risk of Acute Vascular Events (BRAVE) Study: objectives and design (2015) (31)
Phosphodiesterase 4D and 5-lipoxygenase activating protein genes and risk of ischemic stroke in Sardinians (2009) (31)
Genetic determinants of lipids and cardiovascular disease outcomes: a wide-angled Mendelian randomization investigation (2019) (31)
Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease (2020) (31)
Circulating procoagulant microparticles in acute pulmonary embolism: a case-control study. (2010) (30)
Genetic Determinants of Major Blood Lipids in Pakistanis Compared With Europeans (2010) (29)
Integrative analysis of the plasma proteome and polygenic risk of cardiometabolic diseases (2019) (29)
Association of COVID-19 With Major Arterial and Venous Thrombotic Diseases: A Population-Wide Cohort Study of 48 Million Adults in England and Wales (2022) (28)
Effect of communicating phenotypic and genetic risk of coronary heart disease alongside web-based lifestyle advice: the INFORM Randomised Controlled Trial (2019) (27)
Interventions to reduce vasovagal reactions in blood donors: a systematic review and meta‐analysis (2016) (27)
Feasibility and Clinical Impact of Live Three‐Dimensional Echocardiography in the Management of Congenital Heart Disease (2006) (27)
A first update on mapping the human genetic architecture of COVID-19 (2022) (27)
Reciprocal congenic lines for a major stroke QTL on rat chromosome 1. (2006) (26)
Lipoprotein signatures of cholesteryl ester transfer protein and HMG-CoA reductase inhibition (2018) (26)
Genomic risk prediction of coronary artery disease in nearly 500,000 adults: implications for early screening and primary prevention (2018) (26)
High preoperative recipient plasma 7β‐hydroxycholesterol is associated with initial poor graft function after liver transplantation (2005) (25)
Socioeconomic Deprivation and Survival After Heart Transplantation in England: An Analysis of the United Kingdom Transplant Registry (2016) (25)
Lipoprotein(a) levels and risk of future coronary heart disease (2008) (23)
Restless legs syndrome is associated with major comorbidities in a population of Danish blood donors. (2018) (23)
Shorter leukocyte telomere length is associated with adverse COVID-19 outcomes: A cohort study in UK Biobank (2021) (23)
Measurement and initial characterization of leukocyte telomere length in 474,074 participants in UK Biobank (2022) (23)
Computed tomography findings in the first few hours of ischemic stroke: implications for the clinician (2000) (22)
Genetic invalidation of Lp-PLA2 as a therapeutic target: Large-scale study of five functional Lp-PLA2-lowering alleles (2016) (22)
Traffic exposures, air pollution and outcomes in pulmonary arterial hypertension: a UK cohort study analysis (2019) (22)
Large genome-wide association study identifies three novel risk variants for restless legs syndrome (2020) (21)
Development and validation of a universal blood donor genotyping platform: a multinational prospective study. (2020) (21)
Clinical utility of genetic variants for cardiovascular risk prediction: a futile exercise or insufficient data? (2012) (21)
Development and Validation of a Clinical and Computerised Decision Support System for Management of Hypertension (DSS-HTN) at a Primary Health Care (PHC) Setting (2013) (21)
β2-Adrenergic Receptor Gene Polymorphisms and Risk of Ischemic Stroke* (2007) (20)
Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity (2017) (20)
Mitochondrial DNA variants modulate N-formylmethionine, proteostasis and risk of late-onset human diseases (2021) (20)
A major population resource of 474,074 participants in UK Biobank to investigate determinants and biomedical consequences of leukocyte telomere length. (2021) (20)
Is the aortic root dilated in obstructive sleep apnoea syndrome? (2008) (19)
Mechanisms of thrombogenesis in atrial fibrillation (2009) (19)
Feasibility and clinical utility of transesophageal echocardiography in the acute phase of cerebral ischemia. (2010) (19)
Recruitment and representativeness of blood donors in the INTERVAL randomised trial assessing varying inter-donation intervals (2016) (19)
Reduced risk of myocardial infarction related to active commuting: inflammatory and haemostatic effects are potential major mediating mechanisms (2010) (19)
Comparison of transesophageal echocardiographic identification of embolic risk markers in patients with lone versus non-lone atrial fibrillation. (2005) (18)
Is von Willebrand factor associated with stroke and death at mid-term in patients with non-valvular atrial fibrillation? (2018) (18)
COVID-19 trajectories among 57 million adults in England: a cohort study using electronic health records (2022) (17)
Safety of blood donation by individuals over age 70 and their contribution to the blood supply in five developed countries: a BEST Collaborative group study (2019) (17)
ACE inhibition and cardiometabolic risk factors, lung ACE2 and TMPRSS2 gene expression, and plasma ACE2 levels: a Mendelian randomization study (2020) (16)
Tomographic Left Ventricular Volumetric Emptying Analysis by Real-Time 3-Dimensional Echocardiography: Influence of Left Ventricular Dysfunction With and Without Electrical Dyssynchrony (2008) (15)
D-dimers in atrial fibrillation: a further step in risk stratification of thrombo-embolism? (2007) (15)
Predictors and outcome impact of perioperative serum sodium changes in a high-risk population. (2015) (15)
Accuracy of four lateral flow immunoassays for anti SARS-CoV-2 antibodies: a head-to-head comparative study (2021) (14)
Distribution of potential cardiac sources of embolism in young and older stroke patients: implications for recurrent vascular events (2006) (14)
NT-proBNP is associated with coronary heart disease risk in healthy older women but fails to enhance prediction beyond established risk factors: results from the British Women's Heart and Health Study. (2010) (14)
Longer-term efficiency and safety of increasing the frequency of whole blood donation (INTERVAL): extension study of a randomised trial of 20 757 blood donors (2019) (13)
Longer-term efficiency and safety of increasing the frequency of whole blood donation (INTERVAL): extension study of a randomised trial of 20 757 blood donors (2019) (13)
A protective role of a cholesteryl ester transfer protein gene variant towards ischaemic stroke in Sardinians (2007) (12)
Effects of adiposity on the human plasma proteome: observational and Mendelian randomisation estimates (2020) (11)
Prediction of Cardiovascular Disease Risk Accounting for Future Initiation of Statin Treatment (2021) (11)
Systematic Coronary Risk Evaluation (SCORE): JACC Focus Seminar 4/8. (2021) (11)
Information and Risk Modification Trial (INFORM): design of a randomised controlled trial of communicating different types of information about coronary heart disease risk, alongside lifestyle advice, to achieve change in health-related behaviour (2015) (11)
Variations in hemoglobin measurement and eligibility criteria across blood donation services are associated with differing low‐hemoglobin deferral rates: a BEST Collaborative study (2020) (10)
Should all patients with non-valvular atrial fibrillation be anticoagulated? (2010) (10)
Modifiable traits, healthy behaviours, and leukocyte telomere length: a population-based study in UK Biobank (2022) (10)
Quality control and removal of technical variation of NMR metabolic biomarker data in ~120,000 UK Biobank participants (2021) (10)
Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity (2018) (10)
Association of Cardiometabolic Multimorbidity With Mortality The Emerging Risk Factors Collaboration (2015) (9)
Plasma Proteomics of Renal Function: A Transethnic Meta-Analysis and Mendelian Randomization Study (2021) (9)
Plant foods, dietary fibre and risk of ischaemic heart disease in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort (2020) (9)
Comparison of four methods to measure haemoglobin concentrations in whole blood donors (COMPARE): A diagnostic accuracy study (2020) (8)
Spontaneous multiple cervical artery dissection: two case reports and a review of the literature. (2004) (8)
Rare and common genetic determinants of metabolic individuality and their effects on human health (2022) (8)
Obesity and cardiovascular disease: mechanistic insights and management strategies. A joint position paper by the World Heart Federation and World Obesity Federation. (2022) (8)
Beta2-adrenergic receptor gene polymorphisms and risk of ischemic stroke. (2007) (8)
Determinants of antithrombotic choice for patent foramen ovale in cryptogenic stroke (2014) (8)
Short-term evolution (9 months) of aortic atheroma in patients with or without embolic events: a follow-up transoesophageal echocardiographic study. (2009) (8)
Whole-exome sequencing identifies rare genetic variants associated with human plasma metabolites (2022) (7)
Correlation between left atrial spontaneous echocardiographic contrast and 5-year stroke/death in patients with non-valvular atrial fibrillation. (2020) (7)
Association of COVID-19 with arterial and venous vascular diseases: a population-wide cohort study of 48 million adults in England and Wales (2021) (7)
Genetic Analyses of Blood Cell Structure for Biological and Pharmacological Inference (2020) (7)
Learning polygenic scores for human blood cell traits (2020) (6)
Risk factors and prediction models for incident heart failure with reduced and preserved ejection fraction (2021) (6)
Chocolate consumption and cardiometabolic disorders (2011) (6)
The influence of rare variants in circulating metabolic biomarkers (2018) (5)
Autologous pericardium annuloplasty: a "physiological" mitral valve repair. (2014) (5)
Genetically Predicted Type 2 Diabetes Mellitus Liability, Glycated Hemoglobin and Cardiovascular Diseases: A Wide-Angled Mendelian Randomization Study (2021) (5)
Commentary on "A meta-analysis but not a systematic review: an evaluation of the Global BMI Mortality Collaboration". (2017) (5)
Transfusion of Uncrossmatched Group O Erythrocyte-containing Products Does Not Interfere with Most ABO Typings. (2019) (4)
Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity (2018) (4)
Association of shorter leucocyte telomere length with risk of frailty (2022) (4)
Efficacy of acute ischemic stroke patients management in an emergency department stroke unit (EDSU). (2005) (3)
Genetic analysis identifies molecular systems and biological pathways associated with household income (2019) (3)
Use of polygenic risk scores and other molecular markers to enhance cardiovascular risk prediction: prospective cohort study and modelling analysis (2019) (3)
Machine learning optimized polygenic scores for blood cell traits identify sex-specific trajectories and genetic correlations with disease (2022) (3)
Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm (2022) (3)
An atlas of genetic scores to predict multi-omic traits (2022) (3)
Including Measures of Chronic Kidney Disease to Improve Cardiovascular Risk Prediction by SCORE2 and SCORE2-OP. (2022) (3)
Cardiovascular Disease Risk Prediction Factors—Reply (2012) (3)
Association of COVID-19 vaccines ChAdOx1 and BNT162b2 with major venous, arterial, and thrombocytopenic events: whole population cohort study in 46 million adults in England (2021) (3)
Older biological age is associated with adverse COVID-19 outcomes: A cohort study in UK Biobank (2021) (3)
Metabolic mediators of body-mass index and cardiovascular risk (2014) (2)
Body-mass index, abdominal adiposity, and cardiovascular risk – Authors' reply (2011) (2)
Efficiency and safety of varying the frequency of whole blood donation: randomised trial of 45,000 donors (2017) (2)
Body-mass index and all-cause mortality – Authors' reply (2017) (2)
Risk thresholds for alcohol consumption – Authors' reply (2018) (2)
Quantifying the contribution of established risk factors to cardiovascular mortality differences between Russia and Norway (2020) (2)
‘N-terminal pro-B-type natriuretic peptide and the prediction of primary cardiovascular events: results from 15-year follow-up of WOSCOPS’ [Eur Heart J (2013); 34(6):443–450] (2013) (2)
Cardiovascular disease risk by assigned treatment using the 2013 and 1998 obesity guidelines (2016) (2)
SCORE2 models allow consideration of sex-specific cardiovascular disease risks by region. (2022) (2)
Genetically personalised organ-specific metabolic models in health and disease (2022) (2)
Mild-to-Moderate Kidney Dysfunction and Cardiovascular Disease: Observational and Mendelian Randomization Analyses (2022) (2)
Impact of a post‐donation hemoglobin testing strategy on efficiency and safety of whole blood donation in England: A modeling study (2023) (1)
2014 European Conference on Donor Health and Management (2015) (1)
CHADS2 SCORE PREDICTS THE OCCURRENCE OF DEATH, STROKE AND HEART FAILURE IN PATIENTS WITH ATRIAL FIBRILLATION: A SINGLE-CENTER COHORT STUDY (2010) (1)
Gene Sequencing Identifies Perturbation in Nitric Oxide Signaling as a Nonlipid Molecular Subtype of Coronary Artery Disease (2022) (1)
New Way to “SCORE” Risk: Updates on the ESC Scoring System and Incorporation into ESC Cardiovascular Prevention Guidelines (2022) (1)
Systematic Mendelian randomization using the human plasma proteome to discover potential therapeutic targets for stroke (2022) (1)
Modifiable traits, healthy behaviours, and leucocyte telomere length (2021) (1)
Depression and Incident Cardiovascular Disease-Reply. (2021) (1)
Investigation of COVID-19 symptoms and potential immunity in the general population (2020) (1)
New Way to “SCORE” Risk: Updates on the ESC Scoring System and Incorporation into ESC Cardiovascular Prevention Guidelines (2022) (1)
Developing Genome-wide Polygenic Risk Scores for Coronary Artery Disease in South Asians (2020) (1)
Developing Non-Laboratory Cardiovascular Risk Assessment Charts and Validating Laboratory and Non-Laboratory-Based Models (2021) (1)
Genetically predicted levels of the human plasma proteome and risk of stroke: a Mendelian Randomization study (2021) (1)
Body mass index as a measure of global adiposity. (2018) (1)
CO-CONNECT: A hybrid architecture to facilitate rapid discovery and access to UK wide data in the response to the COVID-19 pandemic. (2022) (1)
An Expanded Genome-Wide Association Study of Fructosamine Levels Identifies RCN3 as a Replicating Locus and Implicates FCGRT as the Effector Transcript. (2021) (1)
Coronary heart disease. (1971) (1)
Correction: Lipoprotein signatures of cholesteryl ester transfer protein and HMG-CoA reductase inhibition (2020) (1)
The Association of Multiple Biomarkers of Iron Metabolism and Type 2 Diabetes - the EPIC-InterAct Study Short running title: Iron Metabolism and Type 2 Diabetes Incidence (2016) (1)
Abstract 33: PFO in Cryptogenic Stroke: An Analysis of “High Risk” Features on Transesophageal Echocardiography in the Risk of Paradoxical Embolism Database (2013) (1)
Large scale trans-ethnic meta-analyses identify novel rare and common variants associated with blood pressure and hypertension (2016) (1)
Body mass index as a measure of global adiposity. (2018) (1)
Protein-coding variants implicate novel genes related to lipid homeostasis contributing to body-fat distribution (2019) (1)
Abstract 198: PFO and Recurrent Stroke: Predictors Differ In Patients With “Probable Pathogenic” Versus Other PFOs (2013) (1)
Discovery of rare variants associated with blood pressure regulation through meta-analysis of 1.3 million individuals (2020) (1)
466 Relation of Elevated C reative protein to transesophageal echocardiographics findings in non valvular atrial fibrillation (2006) (0)
Abstract 18370: Role and Potential Impact of TEE in Detecting Markers of Thromboembolism in Non Valvular Atrial Fibrillation Patients with a CHADS2 score = 0? (2012) (0)
Systematic Reviews andMeta-and Pooled Analyses (2017) (0)
Prevalence, associated factors and detrimental links to restless legs syndrome in danish blood donors (2017) (0)
Abstract 20397: The Impact of Healthy Lifestyle on Life Expectancy in the U.S. Population (2017) (0)
Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease (2020) (0)
A molecular variant of the at1r gene is a risk factor for ischemic stroke in hypertensive subjects (2004) (0)
Abstract 2869: Mitral Valve Repair using Autologous Pericardium Annuloplasty: Eighteen-Years Experience in 490 Patients (2008) (0)
Abstract 16356: TEE-Detected Left Atrial Spontaneous Contrast is Associated with an Increased Risk of Cardiovascular Events at Long-Term Follow-up in Patients with Non Valvular Atrial Fibrillation with CHADS2 Score = 0 (2012) (0)
Abstract 12841: Mutations in the BMPR2 Gene Are Associated With Worse Survival in Patients With Pulmonary Arterial Hypertension (2015) (0)
Abstract 15234: Cardiovascular Disease Risk Prediction Using Machine Learning: A Prospective Cohort Study of 423,604 Participants (2018) (0)
RECIPROCAL CONGENIC LINES FOR A MAJOR RECIPROCAL CONGENIC LINES FOR A MAJOR RECIPROCAL CONGENIC LINES FOR A MAJOR RECIPROCAL CONGENIC LINES FOR A MAJOR (2006) (0)
ARE VON WILLEBRAND FACTOR AND FACTOR 8 ASSOCIATED WITH CARDIOVASCULAR EVENTS INCLUDING HEART FAILURE IN NON-VALVULAR ATRIAL FIBRILLATION? (2011) (0)
Comorbidities to restless legs syndrome - results from the Danish blood donor study (2017) (0)
Genomic discovery and functional validation of MRP1 as a novel fetal hemoglobin modulator and potential therapeutic target in sickle cell disease. (2023) (0)
A catalog of genetic loci associated with kidney function from analyses of a million individuals (2019) (0)
Inhibition of MRP1 Induces Fetal Hemoglobin through NRF2 Activation to Protect Human Erythroid Cells from Sickling (2022) (0)
Role of echography in atrial fibrillation (2003) (0)
STRIDES: Strategies to improve donor experiences (2019) (0)
The value of additional risk factors for improving 10-year cardiovascular risk prediction in apparently healthy people (2022) (0)
[Low molecular weight heparin and non valvular atrial fibrillation]. (2006) (0)
Mid- and Long-Term Health Risks in Living Kidney Donors (2018) (0)
Prediction of lifetime cardiovascular risk and individual lifetime treatment benefit in four European risk regions: geographic recalibration of the LIFE-CVD model (2022) (0)
Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity (2019) (0)
Author Correction: Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease (2022) (0)
Estimating individual lifetime risk of incident cardiovascular events in adults with type 2 diabetes: an update and geographical calibration of the DIAbetes Lifetime perspective model (DIAL2). (2022) (0)
[Focus on managing AF and preventing stroke]. (2010) (0)
A genome-wide meta-analysis yields 46 new loci associating with biomarkers of iron homeostasis (2021) (0)
A Hybrid Architecture (CO-CONNECT) to Facilitate Rapid Discovery and Access to Data Across the United Kingdom in Response to the COVID-19 Pandemic: Development Study (2022) (0)
Publisher Correction: Discovery of rare variants associated with blood pressure regulation through meta-analysis of 1.3 million individuals (2021) (0)
C-reactive protein and vascular risk: from March to Jupiter. (2010) (0)
Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity (2018) (0)
Epidemiological studies of high density lipoprotein cholesterol and vascular disease (2010) (0)
CLINICAL OUTCOMES ASSOCIATED WITH ENDOSCOPIC RADIAL ARTERY HARVEST: A SYSTEMATIC REVIEW AND SELECTIVE META-ANALYSIS (2015) (0)
Using polygenic risk scores for prioritising individuals at greatest need of a CVD risk assessment (2022) (0)
Validation of cardiovascular risk prediction in Type 2 diabetes through federated cohorts in Europe (2022) (0)
Lessons from the INTERVAL study – Authors' reply (2018) (0)
Genetics of blood lipids among ~300,000 multi-ethnic participants of the Million Veteran Program (2018) (0)
Cost-effectiveness of alternative minimum recall intervals between whole blood donations (2022) (0)
Accelerating Detection of Disease (ADD) Platform Protocol Summary v2.2 by the ADD Science Task and Finish Group, February 2020 (2020) (0)
Risk of myocarditis and pericarditis following COVID-19 vaccination in England and Wales (2022) (0)
Incremental value of risk factor variability for cardiovascular risk prediction in individuals with type 2 diabetes: results from UK primary care electronic health records (2022) (0)
Abstract WP185: Cryptogenic Stroke and Patent Foramen Ovale: Posterior Circulation Strokes Are More Common In Men Than In Women (2013) (0)
Associations of cardiovascular risk factors with venous thromboembolism (2019) (0)
High-Sensitivity Cardiac Troponin Concentration and Risk of First-EverCardiovascular Outcomes in154,052 Participants (0)
The Malaysian Acute Vascular Events Risk (MAVERIK) study: a resource to study genetic and other determinants of first-ever myocardial infarction in Malaysia (Preprint) (2021) (0)
Genetic loci for major lipids in Pakistan (2010) (0)
Association analyses based on false discovery rate implicate 243 susceptibility loci for coronary artery disease (2017) (0)
Genetic Determinants of Major Blood Lipids in Pakistan Is Compared with Europeans Running title: Saleheen et al.; Genetic loci for major lipids in Pakistan (2010) (0)
The Malaysian Acute Vascular Events Risk (MAVERIK) study protocol: studying genetic and other determinants of first-ever myocardial infarction in Malaysia (Preprint) (2021) (0)
Determination of elevated plasma levels of brain natriuretic peptide in patients with TIA and acute ischemic stroke. (2005) (0)
Response to letter regarding article, "Transesophageal echocardiography in cryptogenic stroke and patent foramen ovale analysis of putative high-risk features from the risk of paradoxical embolism database". (2014) (0)
Thrombosis and antithrombotic therapy Anticoagulant vs . antiplatelet therapy in patients with cryptogenic stroke and patent foramen ovale : an individual participant data meta-analysis (2015) (0)
Abstract 16735: Effect of Communicating Phenotypic and Genetic Risk of Coronary Heart Disease Alongside Web-based Lifestyle Advice - The Inform Randomized Clinical Trial (2016) (0)
Using large-scale epidemiological evidence to help evaluate biomarkers in cardiovascular disease (2010) (0)
COGNITIVE IMPAIRMENT IN SUBJECTS WITH OBSTRUCTIVE SLEEP (2018) (0)
Abstract 18286: Left Atrial Spontaneous Echocardiographic Contrast is a Predictor of Cardiovascular Events (Death, Stroke, Heart Failure) Beyond the CHA2DS2VASc Score at Long-term Follow-up in a Single-Center Cohort of Patients with Non Valvular Atrial Fibrillation (2012) (0)
COMBINATION OF CHADS2 INDEX AND LEFT VENTRICULAR EJECTION FRACTION IDENTIFY PATIENTS WITH ATRIAL FIBRILLATION AND HIGHER RISK OF CARDIOVASCULAR EVENTS (2011) (0)
Publisher Correction: Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity (2018) (0)
TEE-DETECTED LEFT ATRIAL THROMBOGENIC MILIEU IS ASSOCIATED WITH INCREASED CARDIOVASCULAR EVENTS IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION (2011) (0)
International Forum on Mitigation Strategies to Prevent Faint and Pre‐faint Adverse Reactions in Whole Blood Donors: Responses (2021) (0)
Investigating Genetic and Other Determinants of First-Onset Myocardial Infarction in Malaysia: Protocol for the Malaysian Acute Vascular Events Risk Study (2022) (0)
Reviewer Acknowledgment (2009) (0)
Usefulness of transesophageal Echocardiography in Early Etiopathogenic Classification of Acute Ischaemic Stroke Patients (2003) (0)
CIRCULATING PROCOAGULANT MICROPARTICLES ARE NOT ASSOCIATED WITH CARDIOVASCULAR EVENTS AT MIDTERM FOLLOW-UP IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION (2011) (0)
Atrial fibrillation and coagulation. (2005) (0)
1131-141 Transesophageal echocardiographic risk markers of thromboembolism are present in patients with lone atrial fibrillation (2004) (0)
38 VITAMIN D AND CARDIOVASCULAR DISEASE (2012) (0)
ROLE OF LESS WELL-DOCUMENTED RISK FACTORS ON STROKE RECURRENCE (2004) (0)
Association of leucocyte telomere length with frailty: a large-scale cross-sectional analysis in UK Biobank (2021) (0)
Admission screening for ischemic heart disease in a Stroke Unit located in an emergency department. (2001) (0)
Socioeconomic Deprivation Is Associated with Worse Survival After Heart Transplantation in England (2016) (0)
Transesophageal markers of thromboembolism in non-valvular atrial fibrillation patients with a CHADS2 score = 0 (2013) (0)
Prognostic signification of left atrial spontaneous contrast in patients with non valvular atrial fibrillation and a CHADS2 score = 0 (2013) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Emanuele Di Angelantonio?

Emanuele Di Angelantonio is affiliated with the following schools:

University of Milan
University of Oxford
Sapienza University of Rome
University of Cambridge